Treatment of Oral Candidiasis in Pregnancy

First Trimester Treatment Options

The American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America recommend clotrimazole troches (10 mg 5 times daily for 7-14 days) for mild oral candidiasis during pregnancy, especially in the first trimester, due to their safety profile and efficacy 1
Systemic azole antifungals such as fluconazole should be strictly avoided during the first trimester due to potential teratogenic effects and risk of birth defects, as warned by the FDA 2

Topical antifungal treatments (clotrimazole troches, nystatin suspension) remain the safest option throughout pregnancy, according to the Infectious Diseases Society of America 1
After the first trimester, if topical therapy fails, oral azole antifungals such as fluconazole may be considered with caution, but only if the benefits clearly outweigh the risks, as suggested by the American College of Obstetricians and Gynecologists 2

For mild oral candidiasis, a 7-14 day course of topical therapy is typically sufficient, as recommended by the Infectious Diseases Society of America 1
For persistent or recurrent infections, treatment duration may need to be extended, according to the Clinical Infectious Diseases guidelines 1

For severe or refractory cases not responding to topical therapy, consultation with infectious disease specialists is recommended, as advised by the Infectious Diseases Society of America 1
Treatment of sexual partners is generally not necessary for oral candidiasis unless they are also symptomatic, according to the Clinical Infectious Diseases guidelines 1

Prescribing oral fluconazole during the first trimester, which could lead to potential teratogenic effects, is a common pitfall to avoid, as warned by the FDA and the American College of Obstetricians and Gynecologists 2
Discontinuing treatment prematurely once symptoms resolve, rather than completing the full course, can lead to recurrence, as noted by the Clinical Infectious Diseases guidelines 1

High-dose fluconazole (≥400 mg daily) has been associated with a specific syndrome of craniosynostosis, characteristic facies, digital synostosis, and limb contractures ("fluconazole embryopathy") in pregnant women, according to the CDC and MMWR Recommendations and Reports 3
For severe, refractory, or disseminated oral candidiasis that fails topical therapy, intravenous amphotericin B (0.3 mg/kg daily) is the safest systemic option during pregnancy, as recommended by MMWR Recommendations and Reports 3
Neonates born to women on chronic amphotericin B at delivery should be evaluated for renal dysfunction and hypokalemia, as stated in MMWR Recommendations and Reports 3
If topical therapy fails after the first trimester, oral azole antifungals such as fluconazole may be considered with extreme caution, but only if benefits clearly outweigh risks, according to MMWR Recommendations and Reports and Clinical Infectious Diseases 3, 4
Immunocompromised pregnant patients with oral thrush should consult with infectious disease specialists, as recommended by MMWR Recommendations and Reports 3
Prophylactic azoles should be discontinued for HIV-infected women who become pregnant, as stated in MMWR Recommendations and Reports 3